Back to updates

Clinical update

New ESC 2026 guideline: cardiovascular disease and chronic kidney disease

The European Society of Cardiology has published a new 2026 guideline focused on the intersection of cardiovascular disease and chronic kidney disease. Explore the official publication from the DOI link below.

Prepared by
Iraq Cardiology Community
Reading time
2 min

Quick summary

The essential point, in one sentence.

Reading companion

A professional question, bounded to this record.

Answers use this update and its recorded sources only; it does not provide individual treatment advice.

The new 2026 ESC Guideline on Cardiovascular Disease and Chronic Kidney Disease provides an updated source for clinicians working across cardiovascular and kidney care. This IraqCardio announcement is an original, concise editorial note and does not reproduce the guideline text or replace clinical judgement.

Official source: European Society of Cardiology and European Heart Journal. DOI: 10.1093/eurheartj/ehag098. Open the publisher record to read the complete guideline, scope, recommendations, and evidence in its original context.

Professional discussion starter

Turn reading into a balanced conversation.

Prompts for professional reflection—not individual treatment advice.

  1. 1Which element of the source most changes how your team would frame Cardiovascular disease and chronic kidney disease?
  2. 2Which limitation or context should be made explicit before discussing application?
  3. 3What question is worth taking to a journal club or multidisciplinary meeting?

Continue reading

Related updates